Bio-Rad Labs (BIO) Tops Q3 EPS by 5c
Tweet
Share
E-mailGet Alerts BIO Hot Sheet
Price: $297.58 +0.50%
Revenue Growth %: -4.3%
Financial Fact:
Weighted average common shares - basic: 29.4M
Today's EPS Names:
CCEL, MHGU, PLG, More
Revenue Growth %: -4.3%
Financial Fact:
Weighted average common shares - basic: 29.4M
Today's EPS Names:
CCEL, MHGU, PLG, More
Join SI Premium – FREE
Bio-Rad Labs (NYSE: BIO) reported Q3 EPS of $0.59, $0.05 better than the analyst estimate of $0.54. Revenue for the quarter came in at $470 million versus the consensus estimate of $495.55 million.
For earnings history and earnings-related data on Bio-Rad Labs (BIO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Jefferies upgrades Shopify to Buy on AI commerce tailwinds, sees 30% upside
- JD.com, Inc (JD) PT Lowered to $37 at Macquarie ahead of earnings
- Sanuwave Q2 2026 revenue tops revised guidance range
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
